Sleep disorders during pregnancy and post‐partum depression: A systematic review and meta‐analysis

Author(s):  
Mahboobeh Maghami ◽  
Seyyed Payam Shariatpanahi ◽  
Danial Habibi ◽  
Motahar Heidari‐Beni ◽  
Negin Badihian ◽  
...  
2019 ◽  
Vol 43 (3) ◽  
pp. 271-277 ◽  
Author(s):  
E. Minaldi ◽  
S. D’Andrea ◽  
C. Castellini ◽  
A. Martorella ◽  
F. Francavilla ◽  
...  

2021 ◽  
Author(s):  
Jacques L. Tamuzi ◽  
Gomer Lulendo ◽  
Patrick Mbuesse ◽  
Thierry Ntambwe

Objective The aim of this systematic review is to provide some evidence on the use of mobile phone communication for improving ARV adherence during pregnancy, as well as to investigate whether text messaging on mobile phones could improve follow up in HIV exposed infants. Methods We did a systematic review and meta-analysis, using CENTRAL (Cochrane Central Register of Controlled Trials), Scopus, MEDLINE via PubMed, Web of Science, and CINAHL to search for studies in English published between 5 may 2016 to May 2021 that assessed the effects of mobile phone in HIV infected pregnant women. We used MetaPro version 3.0 to compute the OR 2 and RR and their 95%CI. We performed random-effects model meta analysis for estimating pooled outcomes. Results Nine studies were included in the meta-analysis. The pooled maternal postpartum retention was (OR 2.20, 95%CI: 1.55 to 3.13, I2 = 53.20%, P < 0.001). In the same line, the pooled odds of ART uptake was (OR 1.5, 95%CI: 1.07 to 2.11, I2 =0%, P = 0.020) and we found statistically significant impact of mobile phone on HIV testing at 6 weeks and above among HIV exposed children (OR 1.89, 95%CI: 1.04 to 3. 48, I2 = OR 1.89, 95%CI: 1.04 to 3. 48, I2 =88.04%, P = 0.032). Conclusion In comparison to our previous review, this updated review focuses on moderate evidence for mobile phone communication in HIV-infected pregnant women. The results showed that using a mobile phone improved maternal post-partum retention, ART uptake, and infant HIV testing at 6 weeks and older.


2018 ◽  
Vol 76 (6) ◽  
pp. 361-366 ◽  
Author(s):  
Gleysson Rodrigues Rosa ◽  
Anthony Terrence O’Brien ◽  
Eduardo de Almeida Guimarães Nogueira ◽  
Vitor Martinez de Carvalho ◽  
Sonia Castedo Paz ◽  
...  

ABSTRACT Multiple sclerosis (MS) is a complex autoimmune and neurodegenerative disease of the central nervous system. Since MS affects mostly fertile women, pregnancy issues often arise in daily practice. The present study assessed the use of postpartum intravenous immunoglobulin (IVIG) in MS. Methods The authors individually searched for records using PubMed, Medline, EMBASE, Cochrane, SciELO, LILACS, and Google Scholar, using the terms “multiple sclerosis” OR “MS” AND “pregnancy” OR “gestation” OR “partum” OR “post-partum” OR “puerperium” AND “immunoglobulin”. Results The initial search returned 321 papers. There were 11 eligible articles selected for the review. In total, 380 patients had received post-natal IVIG to reduce the number of postpartum relapses. The unadjusted number needed to treat was 6.3 for the quantitative and 5.8 for the qualitative analyses. Conclusion The therapeutic effect of IVIG for prevention of postnatal relapses in MS could not clearly be established in this meta-analysis.


2020 ◽  
Vol 51 ◽  
pp. 101279 ◽  
Author(s):  
Joel Reiter ◽  
Alex Gileles-Hillel ◽  
Malena Cohen-Cymberknoh ◽  
Dennis Rosen ◽  
Eitan Kerem ◽  
...  

2015 ◽  
Vol 30 (11) ◽  
pp. 2575-2586 ◽  
Author(s):  
F. Gressier ◽  
A. Letranchant ◽  
O. Cazas ◽  
A.L. Sutter-Dallay ◽  
B. Falissard ◽  
...  

2020 ◽  
Vol 16 (2) ◽  
pp. 219-230 ◽  
Author(s):  
Jinyang Xu ◽  
Qingqing Deng ◽  
Qingsong Qin ◽  
Alexandros N. Vgontzas ◽  
Maria Basta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document